CDTI Innovación and Mondragón Fondo de Promoción, FCR invest in ROBOPEDICS to develop a robotic orthopedic solution for stroke patients

SICC Innvierte, part of CDTI Innovación, has partnered with Mondragón Fondo de Promoción FCR to invest in ROBOPEDICS for the development of a robotic orthopedic solution for stroke patients.

Stroke is the third leading cause of disability worldwide. One of its most severe and common consequences is the inability to walk. Between 20% and 25% of all stroke survivors are unable to walk without full physical assistance and never regain functional mobility. They require wheelchairs for life, suffering the associated health issues and social and emotional disorders.

BIONIC MOBILITY SOLUTIONS, S.L. (ROBOPEDICS) aims to improve the quality of life and health of these individuals. While full rehabilitation is often unattainable, ROBOPEDICS' technological solution allows them to stand and walk again. This helps alleviate numerous health issues and disorders associated with long-term wheelchair use and empowers them to regain independence.

The company’s goal is to develop both the technology and the necessary conditions to enable patients to walk daily, unsupervised, in their own environments—offering a real alternative to wheelchairs and restoring joy and hope to them and their loved ones.

CDTI Innovación, through Innvierte, has completed an investment round in the company alongside Mondragón Fondo de Promoción, FCR, contributing €135,000 as part of a total committed investment of €540,000.

ROBOPEDICS

ROBOPEDICS has a senior team of founders and advisors with extensive experience in leadership roles in multinational companies and some of Spain’s leading hospitals. The team is complemented by young, skilled, and motivated professionals, along with top-tier strategic partners including:

Mondragón Corporation (main investor and industrial partner)
Instituto de Biomecánica de Valencia (scientific partner)
Hospitals including Hospital Clínic, Parc de Salut Mar, and Germans Trias i Pujol (clinical research partners)
Clarke Modet (IP advisor)
Tecno-med Ingenieros (regulatory advisor)

ROBOPEDICS has developed a unique technology called AWAKE, designed specifically for individuals with paralysis or weakness on one side of the body due to a stroke. Unlike traditional exoskeletons—originally developed for spinal cord injuries and which require robotic support on both legs—AWAKE only robots the affected leg, enabling the user to walk. This represents a revolutionary advancement in mobility solutions for stroke patients.

Mondragón Fondo de Promoción, FCR

This fund, managed by Clave Capital, is focused on investing in technology-based companies in areas of interest to the over 100 cooperatives of the Mondragón Group (industry, automotive, B2B solutions, health, etc.). Its goal is to generate positive synergies between portfolio companies and cooperative businesses. Investments typically range between €250,000 and €2,000,000, assuming the risks inherent to seed-stage ventures. The fund has €15 million in assets and a 10–12-year investment horizon.

Innvierte

Innvierte is a CDTI initiative that promotes business innovation by supporting venture capital investment in tech-based or innovative companies. This program operates through Innvierte Economía Sostenible SICC S.M.E., S.A., a closed-end investment company managed internally and supervised by Spain’s CNMV (National Securities Market Commission), with CDTI as sole shareholder.

To date, CDTI Innovación has committed €2.183 billion across 57 investment vehicles, reaching more than 602 companies. Additionally, it has directly invested €632 million in 188 companies through its co-investment line.

Innvierte is part of Spain’s Science, Technology and Innovation Strategy 2021–2027, approved by the Council of Ministers in September 2020. This strategy outlines the goals, reforms, and actions necessary to boost R&D+i growth and impact, forming a key pillar of Spain’s innovation policy for the coming years.

CDTI Innovación

The Centre for the Development of Industrial Technology (CDTI E.P.E.) is the innovation agency of the Ministry of Science, Innovation and Universities. Its mission is to promote business-led technological innovation and ensure that Spanish companies generate and transform scientific and technical knowledge into globally competitive, sustainable, and inclusive growth. In 2024, under its new strategic plan, CDTI provided over €2.3 billion in support to Spanish companies and startups.